Ascendis Pharma A/S (NASDAQ: ASND) today announced the pricing of its underwritten public offering of 4,166,667 American Depositary Shares (“ADSs”) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE